Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (3y) (2013 - 2026)
Powered by 
Analysis
Fennec Pharmaceuticals (FENC) Share-based Compensation Growth (3y) (2013 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 12.91% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 6.35% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 17.49% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 9.95% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 4.55% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 30.98% |
| 10 | Fennec Pharmaceuticals | 432.85 Mn | 391.60 Mn | 17.15 Mn | 12.93% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.93% |
| Dec 31, 2025 | 45.02% |
| Sep 30, 2025 | 9.82% |
| Jun 30, 2025 | 25.14% |
| Mar 31, 2025 | 13.08% |
| Dec 31, 2024 | 6.94% |
| Sep 30, 2024 | -5.68% |
| Jun 30, 2024 | 12.69% |
| Mar 31, 2024 | 17.33% |
| Dec 31, 2023 | 10.22% |
| Sep 30, 2023 | 59.30% |
| Jun 30, 2023 | 110.76% |
| Mar 31, 2023 | 98.03% |
| Dec 31, 2022 | 21.51% |
| Sep 30, 2022 | 142.29% |
| Jun 30, 2022 | 37.48% |
| Mar 31, 2022 | 29.86% |
| Dec 31, 2021 | 60.57% |
| Sep 30, 2021 | 208.25% |
| Jun 30, 2021 | 44.65% |